UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia

Journal of psychiatric research, 2014-06, Vol.53, p.14-22

2014

Volltextzugriff (PDF)

Duloxetine vs. placebo in patients with painful diabetic neuropathy

Pain (Amsterdam), 2005-07, Vol.116 (1), p.109-118

2005

Volltextzugriff (PDF)

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

International journal of general medicine, 2008-12, Vol.1 (default), p.91-102

2008

Volltextzugriff (PDF)

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Seminars in arthritis and rheumatism, 2010-06, Vol.39 (6), p.454-464

2010

Volltextzugriff (PDF)

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Pain (Amsterdam), 2008-06, Vol.136 (3), p.432-444

2008

Volltextzugriff (PDF)

Efficacy and safety of duloxetine in patients with chronic low back pain

Spine (Philadelphia, Pa. 1976), 2010-06, Vol.35 (13), p.E578-E585

2010

Volltextzugriff (PDF)

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

International clinical psychopharmacology, 2008-05, Vol.23 (3), p.161-169

2008

Volltextzugriff (PDF)

Acute and Chronic Antidepressant Drug Treatment in the Rat Forced Swimming Test Model of Depression

Experimental and clinical psychopharmacology, 1997-05, Vol.5 (2), p.107-112

1997

Volltextzugriff (PDF)

Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)

Neuropsychobiology, 2007-01, Vol.56 (2-3), p.73-85

2007

Volltextzugriff (PDF)

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial

Depression and anxiety, 2008-03, Vol.25 (3), p.182-189

2008

Volltextzugriff (PDF)

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

Journal of clinical psychopharmacology, 2004-08, Vol.24 (4), p.389-399

2004

Volltextzugriff (PDF)

Measures of outcome for stimulant trials: ACTTION recommendations and research agenda

Drug and alcohol dependence, 2016-01, Vol.158, p.1-7

2016

Volltextzugriff (PDF)

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

European neuropsychopharmacology, 2004-12, Vol.14 (6), p.457-470

2004

Volltextzugriff (PDF)

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

The journal of clinical psychiatry, 2002-04, Vol.63 (4), p.308-315

2002

Volltextzugriff (PDF)

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

Psychopharmacology, 1995-09, Vol.121 (1), p.66-72

1995

Volltextzugriff (PDF)

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression

Current pharmaceutical design, 2005-05, Vol.11 (12), p.1475-1493

2005

Volltextzugriff (PDF)

Duloxetine in the treatment of major depressive disorder: an open-label study

BMC psychiatry, 2007-08, Vol.7 (1), p.43-43, Article 43

2007

Volltextzugriff (PDF)

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

The journal of clinical psychiatry, 2004-04, Vol.65 (4), p.521-530

2004

Volltextzugriff (PDF)

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

Journal of clinical psychopharmacology, 2007-12, Vol.27 (6), p.672-676

2007

Volltextzugriff (PDF)

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

Psychopharmacologia, 1999-11, Vol.147 (2), p.162-167

1999

Volltextzugriff (PDF)

The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

BMC psychiatry, 2004-09, Vol.4 (1), p.26-26, Article 26

2004

Volltextzugriff (PDF)

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

Journal of psychiatric research, 2002-11, Vol.36 (6), p.383-390

2002

Volltextzugriff (PDF)

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

The journal of clinical psychiatry, 2005-06, Vol.66 (6), p.686-692

2005

Volltextzugriff (PDF)

Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder

Journal of clinical psychopharmacology, 2015-12, Vol.35 (6), p.654-660

2015

Volltextzugriff (PDF)

Is PTSD caused by traumatic stress?

Journal of anxiety disorders, 2007-01, Vol.21 (2), p.176-182

2007

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(77)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Humans
(47)
Duloxetine Hydrochloride
(41)
Male
(41)
Psychiatry
(39)
Female
(36)
Thiophenes - Therapeutic Use
(36)
Treatment Outcome
(33)
Biological And Medical Sciences
(32)
Double-Blind Method
(32)
Psychology. Psychoanalysis. Psychiatry
(31)
Adult
(30)
Medical Sciences
(29)
Depressive Disorder, Major - Drug Therapy
(26)
Middle Aged
(25)
Neuropharmacology
(23)
Pharmacology. Drug Treatments
(23)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(23)
Psychopharmacology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia

Duloxetine vs. placebo in patients with painful diabetic neuropathy

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Efficacy and safety of duloxetine in patients with chronic low back pain

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

Acute and Chronic Antidepressant Drug Treatment in the Rat Forced Swimming Test Model of Depression

Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

Measures of outcome for stimulant trials: ACTTION recommendations and research agenda

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression

Duloxetine in the treatment of major depressive disorder: an open-label study

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder

Is PTSD caused by traumatic stress?

Suchergebnisse filtern